Dare Bioscience Inc (DARE):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Dare Bioscience Inc (DARE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7842
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body’s normal cells, and enable therapeutic combinations. Its products include ovaprene, a clinical stage, non-hormonal contraceptive ring that provides protection over multiple weeks of use; and topical 5% sildenafil citrate cream for women with female sexual arousal disorders. The company develops and markets therapies for women in the areas of contraception, vaginal health, sexual health and fertility. Dare Bioscience is headquartered in San Diego, California, the US.

Dare Bioscience Inc (DARE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dare Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dare Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dare Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dare Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Dare Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Dare Bioscience Inc, Medical Equipment, Deal Details 10
Partnerships 10
Dare Bioscience to Enter into Agreement with CONRAD 10
Merger 11
Dare Bioscience to Merge with Pear Tree Pharma 11
Equity Offering 12
Dare Bioscience to Raise USD4.1 Million in Public Offering of Shares 12
Dare Bioscience to Raise Funds through Public Offering of Shares 13
Dare Bioscience Raises USD20.7 Million in Equity Financing 14
Dare Bioscience Inc – Key Competitors 15
Dare Bioscience Inc – Key Employees 16
Dare Bioscience Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Sep 17, 2018: Dare Bioscience names Greg Matz as board director 18
Jun 06, 2018: Dare Bioscience Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer 19
Jun 04, 2018: Dare Bioscience Appoints Mary Jarosz To Global Head Of Regulatory Affairs 20
May 08, 2018: Dare Bioscience Expands Leadership Team, Appointing John Fair to Chief Business Officer 21
Apr 11, 2018: Jessica Grossman Joins Dare Bioscience Board of Directors 22
Legal and Regulatory 23
Jul 20, 2017: Daré Bioscience trading on The NASDAQ Capital Market under the symbol “DARE” 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Dare Bioscience Inc, Medical Equipment, Key Facts, 2017 2
Dare Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Dare Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dare Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dare Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dare Bioscience Inc, Deals By Market, 2012 to YTD 2018 8
Dare Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Dare Bioscience to Enter into Agreement with CONRAD 10
Dare Bioscience to Merge with Pear Tree Pharma 11
Dare Bioscience to Raise USD4.1 Million in Public Offering of Shares 12
Dare Bioscience to Raise Funds through Public Offering of Shares 13
Dare Bioscience Raises USD20.7 Million in Equity Financing 14
Dare Bioscience Inc, Key Competitors 15
Dare Bioscience Inc, Key Employees 16
Dare Bioscience Inc, Subsidiaries 17

List of Figures
Dare Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Dare Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Dare Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Dare Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Dare Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dare Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Dare Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dare Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Dare Bioscience Inc (DARE):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • BNP Paribas SA:企業のM&A・事業提携・投資動向
    BNP Paribas SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNP Paribas SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Emcure Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures and markets a range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. It also manufactures active pharmaceutical ingredients (APIs) primarily f …
  • ScanSource Inc (SCSC):企業の財務・戦略的SWOT分析
    ScanSource Inc (SCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BioDiem Ltd:企業の戦略的SWOT分析
    BioDiem Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Methode Electronics Inc (MEI):企業の財務・戦略的SWOT分析
    Summary Methode Electronics Inc (Methode) is technology company. The company offers products such as user interface, lighting, sensors, medical devices, power distribution and digital data. Its user interface products include, guages, cameras, bell pushers, industrial remote controls, touch panels, …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • X4 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiencies. It …
  • LifeArc:企業のM&A・事業提携・投資動向
    LifeArc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LifeArc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Sto SE & Co KGaA:企業の戦略・SWOT・財務情報
    Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Smrt Corporation Ltd.:企業の戦略・SWOT・財務分析
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vedanta Ltd:企業のM&A・事業提携・投資動向
    Vedanta Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Max Life insurance Co. Ltd.:企業の戦略・SWOT・財務情報
    Max Life insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Max Life insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向
    Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆